Clinical Re-evaluation of Daytime Sedatives
- 1 October 1959
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 26 (4) , 502-509
- https://doi.org/10.1080/00325481.1959.11712643
Abstract
Phenobarbital, butabarbital sodium, acetylcarbromal, glutethimide, meprobamate and prochlorperazine were evaluated under conditions of clinical practice to determine their relative effectiveness in producing daytime sedation, nighttime hypnosis by multiple daytime dosages, and combined daytime sedation and nighttime hypnosis. A therapeutic index (per cent effectiveness: per cent untoward reactions) was established for each drug. Butabarbital sodium provided the highest rating of sedatives studied for control of anxiety and insomnia by daytime dosages.Keywords
This publication has 28 references indexed in Scilit:
- A Study of Barbiturate ClearanceActa Medica Scandinavica, 2009
- COUNCIL ON DRUGSJAMA, 1958
- Reactions with Drug TherapySouthern Medical Journal, 1955
- The phenobarbital sensitivity syndromeThe American Journal of Medicine, 1953
- ADDICTION TO BARBITURATES AND THE BARBITURATE ABSTINENCE SYNDROMEAnnals of Internal Medicine, 1950
- EXFOLIATIVE DERMATITIS AND HEPATITIS DUE TO PHENOBARBITALJAMA, 1950
- DERMATITIS DUE TO BARBITURATES: REPORT OF A CASE WITH ASSOCIATED ANEMIAAnnals of Internal Medicine, 1944
- Granulocytopenia Following Barbiturate TherapyNew England Journal of Medicine, 1940
- THE PRESENT STATUS OF THE BARBITURATE PROBLEMPhysiological Reviews, 1939
- SKIN ERUPTIONS WITH PHENOBARBITAL (LUMINAL)JAMA, 1928